PDT Partners’s Harmony Biosciences HRMY Stock Holding History

PDT Partners’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Sell	26,835 -2,992	-10%	-$94.4K	0.05%	329
2026 Q1	$835K	Hold	29,827	–	–	0.05%	364
2025 Q4	$1.12M	Buy	29,827 +12,486	+72%	+$411K	0.07%	336
2025 Q3	$478K	Hold	17,341	–	–	0.03%	456
2025 Q2	$548K	Sell	17,341 -4,335	-20%	-$139K	0.03%	511
2025 Q1	$719K	Sell	21,676 -18,036	-45%	-$647K	0.05%	459
2024 Q4	$1.37M	Sell	39,712 -39,942	-50%	-$1.37M	0.12%	275
2024 Q3	$3.19M	Sell	79,654 -6,514	-8%	-$229K	0.28%	103
2024 Q2	$2.6M	Hold	86,168	–	–	0.25%	138
2024 Q1	$2.89M	Sell	86,168 -6,398	-7%	-$205K	0.27%	119
2023 Q4	$2.99M	Buy	92,566 +36,629	+65%	+$1.02M	0.33%	83
2023 Q3	$1.83M	Sell	55,937 -40,697	-42%	-$1.41M	0.23%	146
2023 Q2	$3.4M	Buy	96,634 +17,856	+23%	+$616K	0.47%	47
2023 Q1	$2.57M	Buy	78,778 +47,625	+153%	+$2.17M	0.35%	93
2022 Q4	$1.72M	Buy	+31,153	New	+$1.71M	0.28%	105

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PDT Partners's HRMY Position: Q2 2026 in Review

PDT Partners reduced its Harmony Biosciences (HRMY) stake by 10% in Q2 2026, selling an estimated $94.4K and leaving 26,835 shares worth $977K. The position accounts for 0.05% of the portfolio, ranked #329.

PDT Partners first reported a position in HRMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.4M in Q2 2023. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

PDT Partners held 26,835 shares of Harmony Biosciences worth $977K as of Q2 2026.
PDT Partners sold 2,992 Harmony Biosciences shares in Q2 2026, an estimated $94.4K.
Harmony Biosciences made up 0.05% of PDT Partners's portfolio in Q2 2026, its #329 holding.
PDT Partners first reported a position in Harmony Biosciences in Q4 2022 and has held it in 15 quarters since.
PDT Partners's Harmony Biosciences position peaked at $3.4M in Q2 2023.
327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.